SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 52 filers reported holding SAGE THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,571,000 | -23.1% | 25,219 | -1.7% | 0.01% | -25.0% |
| Q2 2017 | $2,044,000 | +20.8% | 25,666 | +7.8% | 0.01% | +14.3% |
| Q1 2017 | $1,692,000 | +7.9% | 23,806 | -22.5% | 0.01% | 0.0% |
| Q4 2016 | $1,568,000 | +11.1% | 30,716 | +0.2% | 0.01% | +16.7% |
| Q3 2016 | $1,411,000 | +61.4% | 30,650 | +5.7% | 0.01% | +50.0% |
| Q2 2016 | $874,000 | +22.9% | 29,000 | +30.7% | 0.00% | +33.3% |
| Q1 2016 | $711,000 | -42.3% | 22,192 | +5.0% | 0.00% | -40.0% |
| Q4 2015 | $1,233,000 | +50.7% | 21,143 | +9.4% | 0.01% | +25.0% |
| Q3 2015 | $818,000 | -46.5% | 19,327 | -7.6% | 0.00% | -33.3% |
| Q2 2015 | $1,528,000 | +21.5% | 20,927 | -16.4% | 0.01% | +20.0% |
| Q1 2015 | $1,258,000 | +42.5% | 25,041 | +3.7% | 0.01% | +25.0% |
| Q4 2014 | $883,000 | +438.4% | 24,138 | +365.0% | 0.00% | +300.0% |
| Q3 2014 | $164,000 | – | 5,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Rock Ventures, LLC | 9,773,073 | $490,901,000 | 52.36% |
| Ghost Tree Capital, LLC | 240,000 | $12,056,000 | 2.17% |
| EcoR1 Capital, LLC | 112,455 | $5,649,000 | 1.88% |
| New Leaf Venture Partners, L.L.C. | 43,770 | $2,199,000 | 1.49% |
| AlpInvest Partners B.V. | 12,195 | $613,000 | 1.15% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 595,443 | $29,909,000 | 0.97% |
| APEX CAPITAL, LLC | 190,000 | $9,544,000 | 0.69% |
| OAK RIDGE INVESTMENTS LLC | 385,770 | $19,377,000 | 0.43% |
| Lombard Odier Asset Management (USA) Corp | 92,089 | $4,626,000 | 0.37% |
| SPHERA FUNDS MANAGEMENT LTD. | 65,724 | $3,301,000 | 0.34% |